📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HLA-A30:01 and HLA-A33:03 are the protective alleles while HLA-A*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China. (2018)

First Author: Alifu M

Attributed to: Cellular immunity and genetic restriction of Influenza, Hepatitis C virus infection and Hepatitis B associated heptocellular carcinoma. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4103/0973-1482.199430

PubMed Identifier: 30488842

Publication URI: http://europepmc.org/abstract/MED/30488842

Type: Journal Article/Review

Volume: 14

Parent Publication: Journal of cancer research and therapeutics

Issue: 6

ISSN: 1998-4138